Osteopontin and fatty acid binding protein in ifosfamide-treated rats
Dobrek Łukasz,
Arent Zbigniew,
Nalik-Iwaniak Klaudia,
Fic Kinga,
Kopańska Marta
Affiliations
Dobrek Łukasz
Independent Researcher cooperating with Experimental and Innovative Medicine Centre, University Centre of Veterinary Medicine UJ-UR, University of Agriculture in Krakow, KrakowPoland
Arent Zbigniew
Independent Researcher cooperating with Experimental and Innovative Medicine Centre, University Centre of Veterinary Medicine UJ-UR, University of Agriculture in Krakow, KrakowPoland
Nalik-Iwaniak Klaudia
Independent Researcher cooperating with Experimental and Innovative Medicine Centre, University Centre of Veterinary Medicine UJ-UR, University of Agriculture in Krakow, KrakowPoland
Fic Kinga
Independent Researcher cooperating with Experimental and Innovative Medicine Centre, University Centre of Veterinary Medicine UJ-UR, University of Agriculture in Krakow, KrakowPoland
Kopańska Marta
Department of Human Physiology, Faculty of Medicine, University of Rzeszow, RzeszowPoland
Ifosfamide (IF) is a cytostatic that exhibits adverse nephrotoxic properties. Clinically, IF-induced nephrotoxicity takes various forms, depending on applied dose and length of treatment.
